SK
Surendra Kumar Srivastava
About Surendra Kumar Srivastava
Data last updated:
Surendra Kumar Srivastava has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Mortiyan-Byk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mortiyan-Byk Pharmaceuticals Private Limited at ₹50,000 (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mortiyan-Byk Pharmaceuticals Private Limited U74999UP2018PTC105269 | Director | 13 Jun 2018 | 2018 | ₹50,000 (FY 2020) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surendra Kumar Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surendra Kumar Srivastava
Surendra Kumar Srivastava has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Mortiyan-Byk Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Mortiyan-Byk Pharmaceuticals Private Limited at ₹50,000 (FY 2020).
Surendra Kumar Srivastava is associated with 1 company as Director, including Mortiyan-Byk Pharmaceuticals Private Limited (₹50,000).
Surendra Kumar Srivastava has expertise in General Business.
Surendra Kumar Srivastava has 8 years in corporate governance.
By reported revenue, the largest current company of Surendra Kumar Srivastava is Mortiyan-Byk Pharmaceuticals Private Limited, with revenue of ₹50,000 (FY 2020).
Surendra Kumar Srivastava currently holds positions at 1 company: Mortiyan-Byk Pharmaceuticals Private Limited (₹50,000).